antibody-based therapy (OPKO)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameantibody-based therapy (OPKO)
Drug Alias Nameantibody-based therapy (Cytochroma)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHyperphosphatemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOpko Renal Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsHyperphosphatemia

Other Information

ATC CodeN/A
Related LinksN/A